 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Dainippon Pharmaceutical Co., Ltd.
 |
Dainippon Pharmaceutical Co., Ltd. |
 |
 |
 |
PROFILE |
 |
Get high with Dai! Dainippon Pharmaceutical is one of five firms in Japan licensed to manufacture and sell narcotics for medical use; the company's products include ANPEC and KADIAN, morphine preparations for cancer pain treatment. Dainippon also produces allergy treatments, cardiovascular disorder drugs, and antifungal chemotherapeutics. The company is selling its epileptic seizure drug ZONEGRAN on the US market with Irish pharmaceutical giant Elan. In addition, Dainippon makes food and feed additives, veterinary drugs, and diagnostic products.
COMPETITION |
 |
Sankyo Co., Ltd. (4501)
Takeda Chemical Industries, Ltd. (4502)
Yamanouchi Pharmaceutical Co., Ltd. (dossier)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: March
2000 Sales (mil.): 1,473.80
1-Yr. Sales Growth: 19.9%
Employees: 2,521
Revenue per employee: $584,609.28
KEY PEOPLE |
 |
Kenjiro Miyatake
CEO
Toshihauru Akai
CFO
CONTACT INFO |
 |
6-8 Doshomachi 2-chome, Chuo-ku
Osaka 541-0045, Japan
Phone: 81-662-5307
Fax: 81-662-6581
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |